A case of successful conservative therapy of patient with severe heart failure caused by ischemic heart disease: case report by M. T. Beishenkulov, Z. M. Chazymova, K. R. Kaliev, A. K. Toktosunova, Y. M. Madyarova, M. Kh. Dadabaev

“…The assessed 6-minute walk test showed functional class III according to the NYHA classification.…”
Get full text

New possibilities of nephroprotection in patients with chronic heart failure in combination with chronic kidney disease and diabetes mellitus 2 or without it by E. V. Kovalenko, L. I. Markova, O. L. Belaya

“…Impaired kidney function has a negative impact on the course of heart failure in both patients with and without diabetes mellitus. …”
Get full text

Damage to the Cardiovascular System in Patients with SARS-CoV-2 Coronavirus Infection. Part 2: Correction of Myocardial Systolic Dysfunction by V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, I. I. Shvedov, E. E. Bykova, A. A. Ivannikov, L. V. Vasilyeva

“…Assessment of LV systolic function, exercise tolerance (six-minute walk test, TSW), quality of life (questionnaire EQ-5D-5L) were performed.Results. …”
Get full text

Dilated cardiomyopathy evaluation with Imagenomics: combining multimodal cardiovascular imaging and genetics by Kristian Galanti, Ghaith Sharaf Dabbagh, Fabrizio Ricci, Sabina Gallina, Roberta Giansante, Ron Jacob, Edmond Obeng‐Gyimah, Leslie T. Cooper Jr, Sanjay K. Prasad, David H. Birnie, Andrew P. Landstrom, Selma F. Mohammed, Saidi Mohiddin, Mohammed Y. Khanji, Anwar A. Chahal

“…A multimodal non‐invasive imaging approach is essential for accurate morpho‐functional assessment of cardiac chambers and is key to establish the cardiac phenotype and to rule out an underlying ischaemic aetiology. …”
Get full text

Impact of SGLT2 inhibitors on myocardial fibrosis in diabetic HFpEF: a longitudinal study by Arif Albulushi, Kimia M. Askari, Ammar M. Al-Abedi, Malak A. Al-Kulaibi, Murtadha S. Hasan, Zahra Hosseini, Mezon T. Al-Rahman, Desmond B. Tanoh, Amjad S. Hasan, Yaseen Al-Helli, Ahmed Basouni

“…Additional benefits included greater reductions in LVMI (− 8.2 g/m2 vs. − 2.1 g/m2; p = 0.002), improved glycemic control (HbA1c: − 1.2% vs. − 0.4%; p = 0.01), and enhanced functional capacity (+ 45 m vs. + 10 m in 6MWT; p = 0.01). …”
Get full text